To retrospectively determine whether the combined use of automatic tube voltage selection (ATVS) and automatic tube current modulation (ATCM) can effectively reduce radiation dose at contrast material-enhanced liver computed tomography (CT) while maintaining acceptable image quality compared with the use of ATCM alone.
Purpose:
To retrospectively determine whether the combined use of automatic tube voltage selection (ATVS) and automatic tube current modulation (ATCM) can effectively reduce radiation dose at contrast material-enhanced liver computed tomography (CT) while maintaining acceptable image quality compared with the use of ATCM alone.
Materials and Methods:
This study was approved by an institutional review board, and informed consent was waived. Three hundred fourteen consecutive patients suspected of having liver disease were divided into three groups. In two groups, both ATVS and ATCM were used (group A1, n = 97; group A2, n = 101) but with different contrast gain settings; in one group, only ATCM with a fixed tube potential of 120 kV (group B, n = 116) was used. Weighted volume CT dose index and dose-length product, contrast-to-noise ratios (CNRs), and mean image noise were assessed. Qualitative analysis was performed by two board-certified radiologists and one radiology resident. Statistical analysis was performed by using the one-way analysis of variance test, two-tailed paired t test, Kruskal-Wallis test, and noninferiority test.
Results:
In groups A1 and A2, a significant dose reduction was obtained compared with that in group B (P , .0001). The mean dose reduction was 20% in group A1 and 31% in group A2. Furthermore, CNRs were significantly higher in groups A1 and A2 than in group B (P , .0001). Despite the higher image noise in groups A1 and A2, the overall image quality was acceptable.
Conclusion:
Compared with the use of ATCM alone, the combined use of ATVS and ATCM allowed reduction of radiation exposure while maintaining good image quality at contrastenhanced liver CT. 
Patient Population
For this retrospective study, we collected consecutive patient data during the initial Care kV setup period from June to August 2010. Care kV had first been utilized for liver CT in clinical practice at our institution in June 2010. In total, 330 consecutive patients who had undergone quadruple-phase liver CT with a CT scanner (Somatom Definition Dual Source; Siemens Medical Solutions, Forchheim, Germany) were identified. Sixteen of these patients were later excluded from the study because (a) a different reconstruction algorithm (iterative reconstruction in image space) other than B30 filtered back projection had been used (n = 15) or suggested that tube voltage settings should reflect the diagnostic purpose of the CT examination as well as the patient's body size (14, 19) . In addition, several clinical studies have reported the utility of the low tube voltage technique for CT angiography, for abdominal CT examinations, and in pediatric patients (12, (20) (21) (22) . A particularly interesting study was the experimental phantom study performed by Yu et al (14) , which demonstrated the feasibility of a new strategy allowing automatic tube voltage selection (ATVS) based on the patient's body habitus and the specific diagnostic task at hand. On the basis of the core principles of ATVS, which was demonstrated by Yu et al (14) , a new commercially available software (Care kV; Siemens Healthcare, Forchheim, Germany) that allows the simultaneous use of ATVS and ATCM has recently been developed. However, instead of using noise constraint as an image quality index as proposed by Yu et al (14) , the ATVS program (Care kV) utilizes contrast-to-noise ratio (CNR) as the image quality index. To date, this intriguing concept of ATVS has only been tested in one clinical report for CT angiography (23) . Therefore, the purpose of our study was to determine whether the combined use of ATVS and ATCM can effectively reduce radiation dose at contrast material-enhanced liver CT while maintaining acceptable image quality compared with the use of ATCM alone.
Materials and Methods
This study was approved by the institutional review board at Seoul National University Hospital, and the T he use of diagnostic computed tomographic (CT) imaging has increased remarkably during the past 2 decades owing to technologic developments, its increasing availability, and the perception that imaging can play an important role in the detection and staging of disease, as well as in helping to make medical decisions (1) . However, concerns have also been raised regarding potential patient health risks due to radiation exposure (2, 3) . With radiation dose reduction having become a critical issue, various techniques and patient-based dose modulations have been developed to optimize and reduce radiation dose during CT examinations, including x-ray beam collimation, filtration, automatic tube current modulation (ATCM), and lower tube voltage (4) (5) (6) (7) (8) . The general principle for dose management at CT has been that the examination must be medically indicated (justification) and performed by using doses that are as low as reasonably achievable (or ALARA) and consistent with the diagnostic task (9) (10) (11) .
Among the various dose-reduction techniques, ATCM, which enables automatic adjustment of tube current based on size and attenuation characteristics of the body part being scanned, has been the most frequently used method for dose reduction. Still, other considerations, such as adjusting tube voltage on the basis of patient size or iterative reconstruction techniques, have been proposed, which also result in further dose reduction (11) (12) (13) (14) (15) (16) (17) (18) To initiate ATVS, users must first select one appropriate setting from 12 settings on the basis of the diagnostic purpose of the CT examination. Diagnostic purpose means more or less the relevance of iodine contrast in a tradeoff between image noise and contrast enhancement in our study (Table 1) . For the purposes of liver CT in this study, two ATVS gain settings (eighth and 10th ATVS settings in Table 1 ) were used on the basis of the theoretical estimation of the most appropriate setting and the vendor's recommendations (Appendix E1 [online]). For the tube voltage selection process of the Care kV program, CT projection radiographs ("topograms") for each patient were used to analyze each patient's size and attenuation characteristics. Once the diagnostic task was determined, patient-specific tube current curves were calculated for all tube voltage levels ( Fig E1 [online] ) necessary to deliver the desired image quality on the basis of the selected scan range on the patient's topogram. The program then calculated the estimated radiation dose on the basis of these tube voltage-specific tube current curves for all of the tube voltage levels to determine the optimal dose efficiency. Once the optimal settings were determined, the tool took into account scanner limitations such as maximum tube current or restrictions due to limited heat capacity. If the selected setting was not possible because of the previously stated limitations, the next best tube voltage setting was suggested.
CT Protocol
For all patients, quadruple-phase CT consisting of precontrast, arterial phase (AP), portal venous phase (PVP), and were divided into three groups on the basis of the study period and protocol used and ultimately comprised our study population. In the first third of the study period, 97 patients underwent CT scanning by using the Care kV program with the eighth ATVS setting (group A1). In the middle third of the study period, 101 patients underwent CT examination by using the Care kV program with the 10th ATVS setting (group A2). The remaining 116 patients underwent CT scanning by using the standard protocol of ATCM only with a fixed tube potential of 120 kV in the last third of the study period (group B). As we utilized patient data of the initial protocol setup period, reverting to ATCM with a fixed tube potential was done to allow sufficient time to review the images obtained from ATVS and ATCM and then to determine the contrast gain factor. No significant differences in age (P = .37, one-way analysis of variance test), body mass index (BMI) distribution (P =.72, one-way analysis of variance test), or sex (P = .32, x 2 test) were observed among the three patient groups. In addition, the presence of underlying disease (ie, chronic liver disease or liver cirrhosis) and the distribution of Child-Pugh score did not differ significantly among the three groups (P = .84 and .78, respectively, x 2 test).
Principle of ATVS Program
The ATVS program (Care kV) is designed to automatically recommend the tube voltage setting that provides the lowest radiation dose among four tube voltage settings (80, 100, 120, and 140 kV) for each individual patient dependent on the diagnostic task to be performed. To ensure equivalence in image quality, Care kV pays close attention to matching the CNR at each tube voltage on the basis of the concept of "contrast gain," defined as the ratio of iodine ) independently analyzed the AP and PVP liver CT images at the same picture archiving and communication system workstation (Maroview; Marotech, Seoul, Korea) on a 5-megapixel liquid crystal display monitor. The reading order of the 314 liver CT studies was randomized. For blind evaluation, images presented to the radiologists did not include patient demographics or CT parameters. Although the images were initially presented on a preset soft-tissue window (window width, 350 HU; window level, 40 HU), the readers were allowed to adjust the window setting at their discretion. The three readers were asked to rank the quality of the images on the basis of a previously reported three-point or five-point scoring scheme (Appendix E3 [online]) (4, 20, 27) . The assessment of image noise, overall image quality, and visibility of small vascular structures was according to a five-point scale, while the evaluation of beam-hardening artifacts and abdominal-organ enhancement was done by using a three-point scale. On both AP and PVP images, image noise, beam-hardening artifacts, and overall image quality were assessed. Furthermore, visibility of small vascular structures was evaluated on AP images, and abdominal-organ contrast enhancement was evaluated on PVP images.
Lesion Analysis: Hypervascular Hepatocellular Carcinomas Among the 314 patients, 35 (group A1, n = 10; group A2, n = 12; group B, n = 13) had solitary or multiple hypervascular hepatocellular carcinoma nodules. In total, 46 hypervascular tumors (group A1, n = 15; group A2, n = 12; group B, n = 19) were identified in 35 patients. Proof of hepatocellular carcinoma was not obtained Note.-All numbers stand for the contrast gain at the given tube voltage, defined as the relative ratio of iodine versus water or soft-tissue attenuation difference at a given tube voltage relative to that at 140 kV, considered a reference of 1 at contrastenhanced CT. From ATVS settings 1 to 12, "quality of reference tube current" for each tube potential is modified, and in each row, the same image quality in terms of iodine CNR is maintained in all tube voltages. The ATVS setting 1 is the reference setting without any contrast material, in which equal noise and equal radiation dose is obtained along all four tube voltages; ATVS setting 12 makes maximum use of iodine contrast gain at lower tube voltages (iodine contrast gain 1.980 when going from 140 kV to 80 kV) and allows the highest image noise at lower tube voltage. The ATVS setting from 2 to 11 represents contrast gain values that are mainly linear interpolations from ATVS setting 1 to ATVS setting 12. In this study, two different ATVS settings were applied for groups A1 and A2 (contrast gain of 1.624 and 1.802, respectively, when going from 140 to 80 kV).
Bonferroni correction for multiple comparisons. Interobserver agreement was measured by using the k test (28) . All statistical analyses were performed by using commercially available software (SPSS, version 17.0; SPSS, Chicago, Ill). For all studies, a difference with a P value of less than .05 was considered significant.
Results
Recommended Tube Potentials and Their Radiation Dose CT examinations for groups A1 and A2 were performed with the recommended tube potential provided by the ATVS program; the recommended radiation doses are shown in . The tumor-toliver contrast then was calculated as the attenuation difference between the hypervascular tumor and liver parenchyma (25) . The tumor-to-liver contrast was measured and averaged in all lesions in cases with fewer than three tumors. In cases with three or more lesions, the tumor-to-liver contrast was measured and averaged in the three largest tumors.
Finally, three readers who participated in the qualitative analysis assessed the conspicuity of 50 hypervascular liver tumors, which were annotated with arrows on AP images. Lesion conspicuity was defined as distinguishability from the liver and was evaluated with a five-point scale (score of 1, not distinct; 2, barely distinct; 3, moderately distinct; 4, fairly distinct; 5, definitely distinct) (29,30). Note.-Unless otherwise specified, data are means 6 standard deviations.
* Calculated by using one-way analysis of variance. † Calculated by using Tukey posthoc comparison tests. ‡ Data are numbers of patients, with the percentages in parentheses. § Dose reduction (%) = (CTDI vol of DP 2 CTDI vol of AP)/CTDI vol of DP 3 100.
|| Dose reduction (%) = (DLP of DP 2 DLP of AP)/DLP of DP 3 100, where DLP is dose-length product.
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Qualitative Image Analysis
The image quality scores assigned by the three radiologists and the level of interobserver agreement are shown in Table  5 . With regard to the overall image quality, the scores were the highest in group A1 (3.21 on AP, 3.48 on PVP images), followed by group B (3.13 on AP, 3.05 on PVP images) and group A2 (3.06 on AP, 3.26 on PVP images) (P = .12 for AP, P , .0001 for PVP). ) in group A2, for whom 140 kV was recommended and applied for CT examination.
Comparison of the three groups showed that the mean CT numbers of the aorta and aorta-to-liver on AP images and those of liver, portal vein, and portal vein-to-liver on PVP images were significantly higher in groups A1 and A2 than they were in group B (P , .0001) ( Table 4 ). In addition, the CNR of the aorta and CNR of aorta-to-liver on AP images (33.1 6 0.8 and 32.0 6 0.8 in group A1; 31.3 6 0.9 and 30.1 6 0.9 in group A2; 23.6 6 0.5 and 22.4 6 0.5 in group B, respectively) and the CNR of the liver, portal vein, and portal vein-to-liver on PVP images (5.8 6 0.2, 15.0 6 0.4, and 9.2 6 0.3 in group A1; 5.6 6 0.2, 14.8 6 0.4, and 9.2 6 0.3 in group A2; 4.7 6 0.2, 10.4 6 0.2, and 5.7 6 0.2 in group B, respectively) were significantly higher in groups A1 and A2 than in group B (P , .0001) ( Table 4) . DP showed that there was a significant dose reduction with the combined use of ATVS and ATCM in groups A1 and A2 (P , .0001). In group A1, the mean CTDI vol was 7.7 mGy 6 2.2 (standard deviation) for the AP and 9.4 mGy 6 1.6 for the DP, with a decrease of 20% in group A1 (P , .0001), whereas in group A2, the values were 6.9 mGy 6 3.3 for the AP and 9.6 mGy 6 2.3 for the DP, with a decrease of 31% in group A2. Therefore, dose reduction (in percentages) was greater in group A2 than in group A1 (P , .0001). In addition, in the intergroup analysis among the three groups by using the one-way analysis of variance test, the CTDI vol and dose-length product during the AP were significantly lower in groups A1 and A2 than in group B (P , .0001).
BMI Group Analysis
Correlation between BMIs and recommended tube potentials in groups A1 and A2 is illustrated in Figure 1 . In normal and underweight patients (BMI, ,23 kg/m 2 ) 80 kV was the most frequently selected dose in groups A1 and A2. In overweight patients (BMI, 23-24.9 kg/ m 2 ), 100 kV was the most frequent tube potential used in group A1 and 80 kV was that in group A2. In obese patients (BMI, 25-29.9 kg/m 2 ), 100 kV was the most commonly used tube potential in groups A1 and A2. In severely obese patients (BMI, 30 kg/m 2 or greater), 140 kV was the most frequent tube potential used in group A2. A dose reduction (mean dose reduction, 20% 6 12 [standard deviation] in group A1; 32% 6 15 in group A2) was obtained in all patients with a BMI of less than 30 kg/m 2 . The mean dose reduction was greatest in underweight patients (33% in group A1 [n = 1], 41% 6 1 in group A2 [n = 5]), followed by normal-weight patients (27% 6 10 in group A1 [n = 34], 40% 6 6 in group A2 [n = 33]). However, in severely obese patients, 140 kV was selected, and therefore an increase in the mean radiation dose (7% 6 11 in group A2 [n = 4]) was observed.
Quantitative Image Analysis
Image noise on AP and PVP images was significantly higher in groups A1 and A2 Note.-Data are means 6 standard errors.
* Calculated by using one-way analysis of variance. † Calculated by using Tukey post hoc comparison tests. Note.-Data are means 6 standard deviations. Data in parentheses are numbers that were rated as unacceptable per numbers of total case. If any of the three readers rated the score of 1 (defined as unacceptable) with a five-point rating scale, the case was rated as unacceptable. For PVP images, five cases in group A1 and 15 cases in group A2 were excluded from qualitative analysis because only AP images were obtained by using both ATVS and ATCM and PVP images were acquired with a fixed tube potential of 120 kV for these patients.
* Calculated by using the Kruskal-Wallis test.
GASTROINTESTINAL IMAGING: Automatic Tube Voltage Selection at Liver CT Lee et al conspicuity ( Table 6 ). The tumor-to-liver contrast was significantly higher in groups A1 and A2 than in group B (P , .0001). Statistical analysis revealed that there were no significant differences in lesion conspicuity among the three groups.
Discussion
The main findings of this study were that the combined use of ATVS and ATCM recommends the tube potential with the lowest radiation dose, estimated on the basis of the patient's topograms, and adjusts the tube current for different patient body habitus during liver CT, consequently leading to an effectively reduced radiation dose while maintaining diagnostic image quality. In the qualitative analysis of our study, patients showed neither diagnostically unacceptable range of image noise nor unacceptable image quality in groups A1 and A2 in which ATVS and ATCM were simultaneously used. Moreover, with the newly developed ATVS method, at intraindividual analysis we saw a significant percentage decrease in radiation dose of 20% (7.7 mGy 6 2.2 for AP, 9.4 mGy 6 1.6 for DP) in group A1 and 31% (6.9 mGy 6 3.3 for AP, 9.6 mGy 6 2.3 for DP) in group A2 compared with the results of conventional 120-kV scanning during the DP.
Our results demonstrated that a significant radiation dose reduction was obtained in all patients except the severely obese patients (BMI, .30 kg/ m 2 ). In underweight and normal-weight patients, the radiation dose reduction was greatest as lower tube voltage was selected and used. Severely obese patients, although there were only a small number of patients in our study, required higher tube voltage and radiation dose to obtain a similar image quality. We believe that the combined use of ATVS and ATCM can further increase the range of radiation dose reduction compared with the use of ATCM only, especially in patients with small or regular body habitus (BMI, patients with a high BMI, the evaluation of optimal tube potential, especially higher tube voltages of 120 or 140 kV, is inevitably limited.
In our study, the two different ATVS settings used in groups A1 and A2 were intended to provide contrast gains of 1.624 and 1.891, respectively, when going from 140 to 80 kV. Our results demonstrated that the ATVS setting used in group A1 might be preferred for the liver CT protocol to that in group A2 because of the better scores in all of the qualitative analysis criteria, increased CNRs, and less image noise at quantitative analysis. Furthermore, we also found that group A1 showed similar or slightly better overall image quality score than group B, at the price of higher noise. These results could be related to the diagnostic task of the liver CT scan in our study because detection of reason for the somewhat rare selection of 120 kVp in our study population was that the algorithm for selection of tube potential has a very pure "physics" parameterization in maintaining equal CNR, which may sometimes result in rather nonintuitive behavior (as in the handling of tube voltage switching conflicts). For example, even a relatively small violation of CNR would trigger a switch to 140 kV at the cost of increased dose, rather than sticking to 120 kV with some loss to CNR which would affect image quality minimally but provide lower radiation dose. Therefore, further consideration of correct conflict settings is required with the Care kV system. Second, we believe that the paucity of patients with high BMI in our study group contributed to the even rarer selection of 120 kV in our study. With this small number of can be a successful way to reduce radiation dose.
Interestingly, there were no cases in which 120 kV was recommended by the ATVS program in our study population. From June to August 2010, there were only two patients for whom 120 kV was recommended by Care kV as the optimal tube potential, both of whom were in group A2. However, even these patients were excluded from our study population because one patient had undergone two-phase abdominal and pelvic CT and the other patient had a different reconstruction algorithm used. The main reasons 120 kVp was not selected in groups A1 and A2 were twofold: 18. Vorona GA, Ceschin RC, Clayton BL, Sutcavage T, Tadros SS, Panigrahy A. Reducing abdominal CT radiation dose with the adaptive statistical iterative reconstruction techmaintaining acceptable image quality through the suggestion of tube voltage and current with the lowest radiation dose, calculated relative to the patient's body habitus, anatomic region being studied, and clinical indications.
hypervascular and/or hypovascular focal liver lesions or demonstration of intrahepatic vessels was of primary importance in most patients (13, 29, 32, 33) . The tumor-to-liver contrast in hypervascular hepatocellular carcinomas and the score for visibility of small vasculatures improved with the ATVS setting of group A1 compared with the standard protocol of group B. Moreover, we believe that the ATVS setting used in group A1 might also be effective in the detection of hypovascular hepatic lesions, owing to the improved hepatic parenchymal enhancement compared with group B. However, we did not evaluate whether the combined use of ATVS and ATCM could improve the diagnostic performance of liver CT for detecting hypervascular or hypovascular tumors because we believe that this question would better be answered in a further study. There were some limitations to our study. First, as stated previously, this study was a retrospective study in a single institution, and we did not directly compare different CT protocols. We had decided not to perform a direct comparison of CT protocols because it would have required the test group to receive a substantially higher radiation exposure than that required for clinical practice, making it ethically untenable. Second, because there were only a small number of patients with hypervascular hepatocellular carcinomas, diagnostic accuracy for lesion detection was not evaluated in this study. However, we did assess lesion conspicuity and tumor-to-liver contrast in patients with hypervascular hepatocellular carcinomas. Finally, there was only a limited number of patients with a BMI greater than 30 kg/m 2 , although this may be unavoidable in Asian countries where severely obese patients are relatively rare. Therefore, application of our study results to Western countries would be rather limited, and additional studies to validate the advantages of the synchronous use of ATVS and ATCM in patients with a BMI greater than 30 kg/ m 2 would be required.
In conclusion, the combined use of ATVS and ATCM for liver CT led to significant radiation dose reduction while
